Impaired Mitochondrial Quality Control in Vitiligo: An Emerging Mechanistic Hypothesis and Perspective on Therapeutic Innovation
4 affiliations
- 1Centre for Quality of Health and Living (CQHL), Faculty of Health and Environmental Sciences, Central University of Technology, Bloemfontein 9301, South Africa
- 2Department of Pharmacology, Faculty of Health Sciences, University of the Free State, Bloemfontein 9300, South Africa
- 3Stellenbosch Institute for Advanced Study (STIAS), Wallenberg Research Centre, Stellenbosch University, Stellenbosch 7600, South Africa
- 4Hamburg Institute for Advanced Study (HIAS), Rothenbaumchaussee 45, 20148 Hamburg, Germany
Abstract
Vitiligo is an acquired autoimmune pigmentary disorder characterized by selective melanocyte loss. While oxidative stress and immune dysregulation are well-established contributors, the upstream mechanisms that initiate melanocyte vulnerability remain incompletely understood. In this narrative review, we propose impaired mitochondrial quality control (MQC) as an emerging mechanistic hypothesis that may link key pathogenic events in vitiligo. MQC, encompassing mitophagy, mitochondrial dynamics, and biogenesis, is essential for maintaining melanocyte bioenergetics, redox homeostasis, and survival under ultraviolet (UV) and environmental stress. We summarize current evidence suggesting that abnormalities in PINK1/Parkin-mediated mitophagy, dysregulated fission/fusion dynamics, and impaired PGC-1α/NRF1-driven biogenesis are associated with the accumulation of dysfunctional mitochondria in vitiligo melanocytes. These mitochondrial perturbations may contribute to metabolic adaptation, augmented reactive oxygen species (ROS) production, cytosolic mtDNA release, and downstream innate and adaptive immune activation reported in vitiligo, subsequently driving the characteristic features of vitiligo lesions. However, whether MQC abnormalities represent a primary pathogenic driver, a secondary consequence of chronic oxidative stress, or a bidirectional relationship remains to be established. Thus, we critically discuss the perspective that phytochemicals may act as potential modulators of MQC. Unlike general antioxidants, specific plant-derived compounds such as quercetin, sulforaphane, epigallocatechin gallate (EGCG), and ginkgolides have been reported in preclinical models to modulate mitophagy, rebalance mitochondrial dynamics, and promote biogenesis, thereby targeting mitochondrial homeostasis rather than only its downstream consequences. By repositioning impaired MQC as an attractive, yet to be validated, hypothesis that may offer new insight into vitiligo pathogenesis, this review provides a framework for future investigation and highlights phytochemical-mediated restoration of mitochondrial homeostasis as a potential therapeutic avenue that warrants further experimental validation.
Related
- Engineering extracellular vesicles for inflammatory bowel disease and colitis-associated colorectal cancer: from therapeutic innovation to clinical translation
- Enzyme-Immobilized Nanomaterials for Endocrine Disorders: Therapeutic Innovation and Translational Challenges.
- Targeting Metabolic Drivers of Cardiovascular Disease: Insights for Therapeutic Innovation.
- A Review of the Roles of Calcium Signaling and Homeostasis in Nicotine Addiction: A Mechanistic Hypothesis Involving ATP2B2/PMCA2 and α7-Nicotinic Acetylcholine Receptors
- Delayed Cerebral Ischemia as Progressive Neurovascular Unit Failure: A Hypothesis-Generating Perspective
BibTeX
@article{bandalesole2026impaired,
title = {{Impaired Mitochondrial Quality Control in Vitiligo: An Emerging Mechanistic Hypothesis and Perspective on Therapeutic Innovation}},
author = {Rethabile Banda-Lesole and Ipeleng Kopano Rosinah Kgosiemang-Xaba and Tshepiso Jan Makhafola},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = nov,
doi = {10.3390/ijms272210182},
url = {https://www.mdpi.com/1422-0067/27/22/10182},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Impaired Mitochondrial Quality Control in Vitiligo: An Emerging Mechanistic Hypothesis and Perspective on Therapeutic Innovation
AU - Rethabile Banda-Lesole
AU - Ipeleng Kopano Rosinah Kgosiemang-Xaba
AU - Tshepiso Jan Makhafola
PY - 2026
DA - 2026/11/13
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms272210182
UR - https://www.mdpi.com/1422-0067/27/22/10182
AB - Vitiligo is an acquired autoimmune pigmentary disorder characterized by selective melanocyte loss. While oxidative stress and immune dysregulation are well-established contributors, the upstream mechanisms that initiate melanocyte vulnerability remain incompletely understood. In this narrative review, we propose impaired mitochondrial quality control (MQC) as an emerging mechanistic hypothesis that may link key pathogenic events in vitiligo. MQC, encompassing mitophagy, mitochondrial dynamics, and biogenesis, is essential for maintaining melanocyte bioenergetics, redox homeostasis, and survival under ultraviolet (UV) and environmental stress. We summarize current evidence suggesting that abnormalities in PINK1/Parkin-mediated mitophagy, dysregulated fission/fusion dynamics, and impaired PGC-1α/NRF1-driven biogenesis are associated with the accumulation of dysfunctional mitochondria in vitiligo melanocytes. These mitochondrial perturbations may contribute to metabolic adaptation, augmented reactive oxygen species (ROS) production, cytosolic mtDNA release, and downstream innate and adaptive immune activation reported in vitiligo, subsequently driving the characteristic features of vitiligo lesions. However, whether MQC abnormalities represent a primary pathogenic driver, a secondary consequence of chronic oxidative stress, or a bidirectional relationship remains to be established. Thus, we critically discuss the perspective that phytochemicals may act as potential modulators of MQC. Unlike general antioxidants, specific plant-derived compounds such as quercetin, sulforaphane, epigallocatechin gallate (EGCG), and ginkgolides have been reported in preclinical models to modulate mitophagy, rebalance mitochondrial dynamics, and promote biogenesis, thereby targeting mitochondrial homeostasis rather than only its downstream consequences. By repositioning impaired MQC as an attractive, yet to be validated, hypothesis that may offer new insight into vitiligo pathogenesis, this review provides a framework for future investigation and highlights phytochemical-mediated restoration of mitochondrial homeostasis as a potential therapeutic avenue that warrants further experimental validation.
SN - 1422-0067
ER -